Message Board

Respected readers, authors and reviewers, you can add comments to this page on any questions about the contribution, review,        editing and publication of this journal. We will give you an answer as soon as possible. Thank you for your support!

Name
E-mail
Phone
Title
Content
Verification Code

1997 Vol. 15, No. 5

Cover
Display Method:
1997, (5): 259-264.
Abstract:
Clinical research on deficiency of both qi and yin treated with Yangshengcha
Zhou Wenguang
1997, (5): 264-266.
Abstract:
One hundred and twenty cases with deficiency of both qi and yin were treated with Yangshengcha.The total effective rate 0f the treated group was 96.7%.In the control group of 60 cases,the total effective rate was 88.3%.There was significant difference between two groups (P<0.05).No adverse effect and toxic effect were observed during the clinical observation.
1997, (5): 266-266.
Abstract(1982) PDF (970KB)(688)
Abstract:
1997, (5): 267-269.
Abstract:
1997, (5): 269-270.
Abstract:
1997, (5): 270-270.
Abstract:
1997, (5): 271-273.
Abstract:
1997, (5): 273-276.
Abstract:
1997, (5): 276-276.
Abstract:
1997, (5): 277-278,320.
Abstract:
1997, (5): 279-281.
Abstract:
1997, (5): 281-283.
Abstract(11687) PDF (1652KB)(7892)
Abstract:
1997, (5): 283-283,312.
Abstract(2298) PDF (843KB)(493)
Abstract:
1997, (5): 284-285.
Abstract(2043) PDF (1045KB)(2264)
Abstract:
1997, (5): 285-285.
Abstract(2161) PDF (574KB)(472)
Abstract:
1997, (5): 286-287.
Abstract:
Studies on bioavailability of nimodipine soft capsules in healthy volunteer
Cai Changchun, Li Jingsu, Yang Zunxiang, Xie Xiaochan
1997, (5): 288-290.
Abstract:
A single oral dose of tablets or soft capsules of 60mg nimodipine was given to 8 healthy volunteers in a randomized crossover study.plasma levels were determined with HPLC method.The plasma concentration-time curve fitted 1-compartment open model,and 2 dose comparative Tmax,Cmax,AUC were not significantly different from that of the tablets(P>0.05).Although the sofe capsules could reach peak level faster,the bioavailability with same biological effect.
1997, (5): 290-292.
Abstract:
1997, (5): 292-292.
Abstract:
Study on process of 101 clarificant used for preparing Lingzhi-Huangqi Jing oral liquid
Gao Zhigang, Liu Qiandian, Wang Zhenzhong
1997, (5): 293-295.
Abstract:
101 clarificant was used instead of water-extraction and alcohol-precipitation method in preparing Lingzhi-Huangqi Jing oral liquid.The optimum concentration and precipita tion temperature of 101 clarificant were selected using arthogonal test.101 clarificant can more effectively eliminate impurities,retain polysaccharides,amino acids etc.as compared with the origi nal method.At same time,101 clarificant can lower cost,sirnplify process and prepare high-quality oral liquid.
The test for detecting bacterial endotoxin in procaine hydrochloride iujection by TAL
Wu Wenfei, Liu Mingzhong
1997, (5): 295-297.
Abstract:
The inhibition,enhancement and sensitivity tests of procaine hydrochloride injection for interference were studied with TAL.
1997, (5): 297-298.
Abstract:
Determination of methadone hydrochloride by HPLC
Lin Cai, Dai Qing, Dong Hui, Ma Wenxiu, Liu Songqing
1997, (5): 299-301.
Abstract:
To estab1ish a HPLC method for determining methadone hydrochloride and methadone hydrochloride oral solution.Using a Symmetry-C18 Chlumn,a mixture of acetoni trile-monobasic potassium phosphate(pH2.5)(38:62,V/V)as mobile phase and detected at 220nm bupivacaine hydrochloride was used as internal standard.The average recovery was 100.17%.The RSD for the inter inter and intra-day were all less than 1%.The method is simple,rapid and accurate.
1997, (5): 301-305.
Abstract:
1997, (5): 305-306.
Abstract(2149) PDF (1906KB)(1012)
Abstract:
1997, (5): 306-307.
Abstract:
1997, (5): 308-309.
Abstract:
1997, (5): 309-309.
Abstract(2110) PDF (514KB)(285)
Abstract:
1997, (5): 310-310.
Abstract(2310) PDF (918KB)(332)
Abstract:
1997, (5): 310-310.
Abstract(2316) PDF (918KB)(362)
Abstract:
1997, (5): 311-312.
Abstract:
1997, (5): 313-314.
Abstract(2379) PDF (612KB)(311)
Abstract:
1997, (5): 314-316.
Abstract:
1997, (5): 316-317.
Abstract(1624) PDF (569KB)(347)
Abstract:
1997, (5): 318-319.
Abstract(1689) PDF (440KB)(344)
Abstract:
1997, (5): 319-320.
Abstract: